Clinical observation of the therapeutic effects of pegylated recombinant human granulocyte colony-stimulating factor in patients with concurrent chemoradiotherapy-induced grade IV neutropenia

By  

Experimental and Therapeutic Medicine, Vol. 9, Iss. 3, 2015-01 ,pp. : 761-765

Spandidos Publications

Access to resources Recommend Favorite

Administration of granulocyte colony-stimulating factor with radiotherapy promotes tumor growth by stimulating vascularization in tumor-bearing mice

By                

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 147-154

Spandidos Publications

Access to resources Recommend Favorite

The safety of full-dose chemotherapy with secondary prophylactic granulocyte colony stimulating factor (G-CSF) following a prior cycle with febrile neutropenia

By Haim Nissim   Shulman Katerina   Goldberg Hadassah   Tsalic Medy  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 229-232

Humana Press, Inc

Access to resources Recommend Favorite

Usage of granulocyte colony-stimulating factor every 2 days is clinically useful and cost-effective for febrile neutropenia during early courses of chemotherapy

By Yakushijin Yoshihiro   Shikata Hisaharu   Takaoka Ikue   Horikawa Tamami   Takeuchi Kazuhito   Yamanouchi Jun   Azuma Taichi   Narumi Hiroshi   Hato Takaaki   Yasukawa Masaki  

International Journal of Clinical Oncology, Vol. 16, Iss. 2, 2011-04 ,pp. : 118-124

Springer Publishing Company

Access to resources Recommend Favorite

Granulocyte-Macrophage Colony-stimulating Factor Therapy in Patients With Chemotherapy-induced Aplasia and Clostridium difficile Enterocolitis

By Geiger R.   Fussenegger J.   Allerberger F.   Maurer K.   Fink F.M.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2416-2417

Elsevier

Access to resources Recommend Favorite